Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Characterization of recombinant polioviruses expressing regions of rotavirus VP4, hepatitis B surface antigen, and herpes simplex virus type 2 glycoprotein D.

Mattion NM, Reilly PA, Camposano E, Wu SL, DiMichele SJ, Ishizaka ST, Fantini SE, Crowley JC, Weeks-Levy C.

J Virol. 1995 Aug;69(8):5132-7.

2.
3.

A mutation present in the amino terminus of Sabin 3 poliovirus VP1 protein is attenuating.

Tatem JM, Weeks-Levy C, Georgiu A, DiMichele SJ, Gorgacz EJ, Racaniello VR, Cano FR, Mento SJ.

J Virol. 1992 May;66(5):3194-7.

4.

Identification and characterization of a new base substitution in the vaccine strain of Sabin 3 poliovirus.

Weeks-Levy C, Tatem JM, DiMichele SJ, Waterfield W, Georgiu AF, Mento SJ.

Virology. 1991 Dec;185(2):934-7. Erratum in: Virology 1992 Apr;187(2):845.

PMID:
1660210
5.

Oral poliovirus vaccine in the United States: molecular characterization of Sabin type 3 after replication in the gut of vaccinees.

Tatem JM, Weeks-Levy C, Mento SJ, DiMichele SJ, Georgiu A, Waterfield WF, Sheip B, Costalas C, Davies T, Ritchey MB, et al.

J Med Virol. 1991 Oct;35(2):101-9.

PMID:
1662701

Supplemental Content

Loading ...
Support Center